Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Midazolam recalled?

Yes — there is an active recall. 3 ongoing FDA recalls mention Midazolam (43 total). Check the affected lots below.

Most common reason: Sterility / contamination (23 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Midazolam. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Midazolam recalls on record

none so far in 2026; 43 on record, newest first
Class II · Moderate risk

midazolam in dextrose 5%

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc NDC 71286-4036-1 D-1075-2023
Class II · Moderate risk

Midazolam Injection

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Ongoing Stability / shelf life Akorn, Inc. D-0859-2023
Class II · Moderate risk

Midazolam Injection

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Ongoing Stability / shelf life Akorn, Inc. D-0828-2023
Class II · Moderate risk

Midazolam 1 mg/mL

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 15082-401-76 D-0957-2018
Class II · Moderate risk

Midazolam 0.5mg/mL

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 15082-408-10 D-0956-2018
Class II · Moderate risk

Midazolam 1 mg/mL

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 15082-401-63 D-0955-2018
Class II · Moderate risk

Midazolam 1 mg/mL

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 4252-401-10 D-0937-2018
Class I · High risk

Midazolam Injection

Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 76045-001-20 D-0152-2018
Class II · Moderate risk

Midazolam HCl all strengths

Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Terminated Labeling / mix-up Advanced Pharma Inc. D-0814-2017